Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini Oral session - Developmental and precision medicine

Safety, anti-tumour activity, and biomarker results of the HER2-targeted bispecific antibody ZW25 in HER2-expressing solid tumours

Date

22 Nov 2019

Session

Mini Oral session - Developmental and precision medicine

Topics

Targeted Therapy

Tumour Site

Presenters

Do-Youn Oh

Citation

Annals of Oncology (2019) 30 (suppl_9): ix22-ix29. 10.1093/annonc/mdz420

Authors

D. Oh1, E. Hamilton2, D. Hanna3, M. Beeram4, K. Lee5, Y. Kang6, J. Chaves7, J. Lee8, R. Goodwin9, C. Vaklavas10, S. Rha11, E. Elimova12, J. Mayordomo13, C. Ferrario14, M. Cobleigh15, A. Fortenberry16, G. Rowse17, T. Gray17, R. Lai16, F. Meric Bernstam18

Author affiliations

  • 1 Internal Medicine, Seoul National University Hospital, 110-744 - Seoul/KR
  • 2 Sarah Cannon Research Institute And Tennessee Oncology, Sarah Cannon Research Institute and Tennessee Oncology, Nashville Tennessee/US
  • 3 Usc Norris Comprehensive Cancer Center, USC Norris Comprehensive Cancer Center, Los Angeles/US
  • 4 The Start Center For Cancer Care, The START Center for Cancer Care, San Antonio Texas/US
  • 5 National University Of Seoul Bundang Hospital, National University of Seoul Bundang Hospital, Bundang/KR
  • 6 Asan Medical Center, Asan Medical Center, Bundang/KR
  • 7 Northwest Medical Specialties, Northwest Medical Specialties, Tacoma Washington/US
  • 8 Samsung Medical Center, Sungkyunkwan University School Of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul/KR
  • 9 University Of Ottawa Cancer Centre, University of Ottawa Cancer Centre, Ottawa Ontario/US
  • 10 University Of Alabama Cancer Center, University of Alabama Cancer Center, Birmingham Alabama/US
  • 11 Yonsei Cancer Center, Yonsei University Health System, Yonsei Cancer Center, Yonsei University Health System, Seoul/KR
  • 12 Princess Margaret Cancer Centre, Princess Margaret Cancer Centre, Toronto Ontario/CA
  • 13 University Of Colorado Cancer Center, University of Colorado Cancer Center, Denver Colorado/US
  • 14 Jewish General Hospital, Jewish General Hospital, Montreal Quebec/CA
  • 15 Rush University Medical Center, Rush University Medical Center, Chicago Illinois/US
  • 16 Zymeworks Inc, Zymeworks Inc, Vancouver/CA
  • 17 Zymeworks Inc.,, Zymeworks Inc.,, Vancouver/CA
  • 18 The University Of Texas Md Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Houston Texas/US

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.